| 1 |
30377939 | Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation-Positive NSCLC. | 2019 Aug |
1 |
| 2 |
29888317 | Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4. | 2018 |
2 |
| 3 |
24335566 | A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas. | 2014 Jan |
5 |
| 4 |
24403856 | Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain. | 2013 Dec |
1 |
| 5 |
21903741 | Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study. | 2011 Oct |
1 |
| 6 |
19164239 | PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans. | 2009 Feb |
2 |
| 7 |
17627611 | Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression. | 2007 Sep |
1 |
| 8 |
15093817 | Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors. | 2004 May |
3 |
| 9 |
12573320 | Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride. | 2003 Feb |
1 |